Turing Pharmaceuticals CEO defends 5,000 percent drug price increase
Tuesday, September 22, 2015 - 12:40
in Mathematics & Economics
Andrew V. PestanoWASHINGTON, Sept. 22 (UPI) -- The CEO of Turing Pharmaceuticals has defended the 5,000 percent price increase of the drug Daraprim, used to treat toxoplasmosis, often in AIDS patients.